Pluristem Therapeutics Culture | Comparably

Pluristem Therapeutics Cultura da Companhia

Cultura Pluristem Therapeutics

Essa avaliação vem de colaboradores.

Dimensões de Cultura Mais Bem Avaliadas

N/A

CEO do Pluristem Therapeutics

Zami Aberman Pluristem Therapeutics' CEO
Zami Aberman

Informação de Companhia

Endereço
Building #5, #20
United States of America
Website
pluristem.com
Fundado
2003

Descrição de Companhia

Pluristem Therapeutics uses placental cells and three-dimensional technology to develop cell therapies for various diseases.

Executivos Chave

Nome e Título
Bio
Zami Aberman  CEO / President
Zami Aberman
CEO / President
Mr. Zami Aberman has been Co-Chief Executive Officer of Pluristem Therapeutics Inc. since March 29, 2017. Mr. Aberman served as the Chief Executive Officer of Pluristem Therapeutics, Inc., (Alternate Name: Pluristem Life Systems Inc.) from September 26, 2005 to March 29, 2017. Mr. Aberman has been an Executive Chairman of Pluristem Therapeutics, Inc, since April 3. 2006 and has been its Executive Director since November 21, 2005. Mr. Aberman served as the President of Pluristem Therapeutics, Inc. from September 26, 2005 to February 5, 2014. He has over 20 years of experience in managing industrial companies, international marketing of breakthrough technological solutions to automotive, aerospace, metal industry and flat panel manufacturing, as well as experience in establishing and managing start-up companies active in the field of software development, chip development, advanced system development, flexible automation inspection and image processing. He served Chief Executive and Chairman positions in Israel, the USA, Europe, Japan and Korea. He operated within high-tech global companies in the fields of Automatic Optical Inspection, network security, Video over IP, software, chip design and robotic markets. Since 1996, Mr. Aberman founded and managed high-tech companies active in various fields. He served as the President of Elbit Vision Systems Ltd. and served as its Chief Executive Officer until December 26, 2004. Mr. Aberman served as President and Chief Executive Officer of Netect Ltd, specialized in the field of Internet security software. He was the Co-Founder, President and Chief Executive Officer of Associative Computing Ltd. He served as President and Chief Executive Officer of Robomatix Technologies Ltd., a public company (RBMXF.OB) from 1987 to 1996. He served as an Acting Chairman of Pluristem Therapeutics, Inc. since April 3, 2006. He served as Chairman of Display Inspection Systems Inc. specializing in laser based inspection machines. Mr. Aberman served as the Chairman of Rose Hi-tech Ltd. and VLScom Ltd. Mr. Aberman has been an Executive Director of Pluristem Therapeutics, Inc, He has been a Director of Alliance for Regenerative Medicine since October 2015. Mr. Aberman served as a Director of Ori Software Ltd. In 1992, Mr. Aberman was awarded the Rothschild Prize, for the development of a unique, laser based, flexible manufacturing system for the automotive industry, from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.
William Prather  Senior Vice President Corporate Development
William Prather
Senior Vice President Corporate Development
William Prather Serve de Senior Vice President Corporate Development of Pluristem Therapeutics.

Avise Pluristem Therapeutics Que você Quer trabalhar Lá

Avise Pluristem Therapeutics que você está Interessado em trabalhar para a companhia, ao mesmo tempo matenha a sua anônimidade. Comparably dará Pluristem Therapeutics a oportunidade de te contratar quando uma vaga com a sua cara aparecer!

Pontuação de Gênero Quão positiva é avaliacão de mulheres sobre sua experiência de trabalho em Pluristem Therapeutics

N/A

Pontuação de Diversidade Quão positiva minorias avaliam sua experiência na empresa Pluristem Therapeutics

N/A

Sabe de alguem que trabalha emPluristem Therapeutics?

Enviar a eles uma mensagem para valiar a cultura da companhia

Envie um Convite anônimo

×
Rate your company